Dr Reddy’s recalls nearly 13,000 bottles of anti-hypertensive drugs from US market
Dr Reddy's Laboratories Ltd is recalling 13, 560 bottles of high blood pressure drug Metoprolol succinate from US market due to failure in dissolution test. The recall is a voluntarily started by Dr Reddy’s. Dr Reddy’s is a pharmaceutical company engaged in manufacturing and marketing of wide range of pharmaceuticals in India and overseas. Metoprolol succinate extended release is a cheaper generic form of AstraZeneca Plc's Toprol XL. Wockhardt Ltd has also recalled 109, 744 bottles of the same drug citing the same reason. Dissolution tests are commonly conducted to check the time taken for the active ingredient in a drug to release into the body, and help predict how the drug performs inside the body.
The FDA classified the recall as Class II recall, which means use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences. Dr Reddy's has also recalled about 58,656 bottles of the heartburn drug lansoprazole from the United States in March due to a microbial contamination.